Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Bioverativ Inc.
| Metric | Bioverativ Inc. Healthcare |
|---|---|
| Quality Score | 87 / 100 |
| Revenue (latest) | $259M |
| Net income (latest) | $69M |
| Operating margin | 172.6% |
| Net margin | 26.7% |
| Return on equity | 7.7% |
| Return on assets | 4.3% |
| Return on capital (ROCE) | 36.4% |
| Debt / equity | 0.80× |
| Revenue growth (YoY) | 35.2% |
| Altman Z″ (distress) | 5.41 |
| Accruals / assets | −32.2% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.